Showing results (1891-1900 of 2,287) with videos related to
Sort By:
Pageof 229
Journal of Medicinal Chemistry|February 18, 1994
Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthineD R Buckle, J R Arch, B J Connolly, et al.The American Surgeon|March 22, 2018
Outcomes after Falls Continue to Worsen Despite Trauma and Geriatric Care AdvancementsEric J Charles, Nicholas J Napoli, Lily E Johnston, et al.Assay and Drug Development Technologies|June 18, 2009
Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound libraryPaul A Johnston, Caleb A Foster, Marni Brisson Tierno, et al.Optics Express|February 8, 2013
Modelocking and femtosecond pulse generation in chip-based frequency combsKasturi Saha, Yoshitomo Okawachi, Bonggu Shim, et al.The Journal of Biological Chemistry|June 20, 1998
The mechanism of action of steroidogenic acute regulatory protein (StAR). StAR acts on the outside of mitochondria to stimulate steroidogenesisF Arakane, C B Kallen, H Watari, et al.Molecular Pharmaceutics|January 15, 2026
Utilizing Flux to Inform Formulation Strategy Decisions in Preclinical StudiesLaura I Mosquera-Giraldo, Zina Patel, Dongyue Yu, et al.Journal of Emergency Nursing|January 7, 2026
Interrater Reliability in the Triage of Children With Mental and Behavioral Health Symptoms Using Two Triage SystemsJennifer A Hoffmann, Kimberly Denicolo, Patricia Cobb, et al.Journal of Affective Disorders|August 12, 2024
Clinical and sociodemographic features of the Texas resilience against depression (T-RAD) study: Findings from the initial cohortMadhukar H Trivedi, Manish K Jha, Joshua S Elmore, et al.Journal of Psychiatric Research|August 22, 2021
Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) studyBrett D M Jones, Robert D Levitan, Wei Wang, et al.Oncogene|September 1, 1999
RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteasesJ A Aguirre-Ghiso, P Frankel, E F Farias, et al.Pageof 229